EUVIMEDEUVIMED entdecken
Crossref

Transjugular mesenteric-caval shunt for portal vein cavernous transformation with recurrent variceal bleeding: preliminary results

Jun Tie, Xulong Yuan, Zhengcai Liu, Xiaoyuan Gou, Ying Zhu, Jing Niu, Jiao Xu, Shuqiang Yue, Yongquan Shi

European Radiology · 2024

DOI: 10.1007/s00330-024-11041-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Radiology, 2024. Verfasst von Jun Tie und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xij…. Hauptthemen laut MEDLINE: Portal Vein, Esophageal and Gastric Varices, Gastrointestinal Hemorrhage, Hypertension, Portal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to evaluate the feasibility, safety, and efficacy of the transjugular mesenteric-caval shunt (TMCS) as a treatment for the cavernous transformation of the portal vein (CTPV) and recurrent variceal bleeding. METHODS: This retrospective case series was conducted with approval from the institutional review board. It involved seven patients diagnosed with CTPV and recurrent variceal bleeding who underwent the TMCS procedure. We analyzed the rate of procedural complications, incidents of rebleeding, stent stenosis, hepatic encephalopathy, and overall survival to assess treatment outcomes. RESULTS: The TMCS was successfully performed in all seven patients without any life-threatening complications. Postoperatively, one patient developed a lung infection and pleural effusion, which resolved with appropriate treatment. Additionally, two patients experienced an increase in total bilirubin levels, but there was no further deterioration in liver function. The median portal pressure gradient significantly decreased from a preoperative value of 27 mmHg (range 20-36 mmHg) to a postoperative value of 6 mmHg (range 4-11 mmHg). A notable improvement was observed in one cirrhotic patient, with liver function progressing from Child-Pugh class B (score 9) to class A (score 6). Over a median follow-up period of 14 months (range 7-18 months), none of the patients encountered rebleeding, stent stenosis, hepatic encephalopathy, or mortality. CONCLUSION: The TMCS appears to be a viable and effective alternative for managing CTPV with recurrent variceal bleeding. Its long-term outcome requires further evaluation. CLINICAL RELEVANCE STATEMENT: TMCS provides a promising treatment for patients with life-threatening CTPV complications when occluded portal vein cannot be recanalized and portal vein recanalization TIPS is not an option. KEY POINTS: Performing TIPS in patients with portal vein cavernoma is complex due to the requirement for recanalization of the occluded portal vein. Creating a mesenteric-caval shunt through a transjugular approach is a feasible technique. Establishing a TMCS provides a means to manage life-threatening complications arising from portal vein cavernoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Portal VeinEsophageal and Gastric VaricesGastrointestinal HemorrhageHypertension, PortalHumansMaleFemaleMiddle AgedRetrospective StudiesAdultTreatment OutcomeRecurrenceAgedFeasibility StudiesTomography, X-Ray Computed

Stichwörter der Autor:innen

Cavernous transformation of portal veinOcclusive portal vein thrombosisTransjugular mesenteric-caval shuntVariceal bleedingVascular liver disorders

Autor:innen und Institutionen

  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi'a…
  • Department of General Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China.

Zitieren

APA

Tie, J., Yuan, X., Liu, Z., Gou, X., Zhu, Y., Niu, J., Xu, J., Yue, S., & Shi, Y. (2024). Transjugular mesenteric-caval shunt for portal vein cavernous transformation with recurrent variceal bleeding: preliminary results. European Radiology. https://doi.org/10.1007/s00330-024-11041-7

Vancouver

Tie J, Yuan X, Liu Z, Gou X, Zhu Y, Niu J, et al. Transjugular mesenteric-caval shunt for portal vein cavernous transformation with recurrent variceal bleeding: preliminary results. European Radiology. 2024. doi:10.1007/s00330-024-11041-7

BibTeX
@article{Tie2024,
  author = {Tie, Jun and Yuan, Xulong and Liu, Zhengcai and Gou, Xiaoyuan and Zhu, Ying and Niu, Jing and Xu, Jiao and Yue, Shuqiang and Shi, Yongquan},
  title = {Transjugular mesenteric-caval shunt for portal vein cavernous transformation with recurrent variceal bleeding: preliminary results},
  journal = {European Radiology},
  year = {2024},
  doi = {10.1007/s00330-024-11041-7}
}
Kostenlos starten →